Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial. (2018)
Attributed to:
EPSRC Centre for Mathematical and Statistical Analysis of Multimodal Clinical Imaging
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2018-022452
PubMed Identifier: 30224390
Publication URI: http://europepmc.org/abstract/MED/30224390
Type: Journal Article/Review
Volume: 8
Parent Publication: BMJ open
Issue: 9
ISSN: 2044-6055